The Swiss University of St. Gallen has certified that the Vetter QC Laboratories are of above-average quality.
Vetter is further investing in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site located in…
Five key considerations we share with companies who are deciding where and when to make key decisions about their secondary packaging strategy.
For companies looking to gain a competitive edge, pen injectors and cartridges offer an attractive solution.
Biologics are often particularly prone to particle formation. Particle analysis becomes more important.
A jury of experts are convinced: Vetter is a symbol for the future of Germany as a business location!
Why you should consider defining your secondary packaging strategy as early as possible.
by Joerg Zimmermann, Vice President Vetter Development Service, External Affairs
By Claus Feussner, Ph. D., Senior Vice President Vetter Development Service
Meet us at 2021 PDA Universe of Pre-Filled Syringes and Injection Devices Conference.